These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12284919

  • 1. [Pharmacokinetic and pharmacodynamic studies on vaginally administered levonorgestrel].
    He CH.
    Shengzhi Yu Biyun; 1991 Nov; 11(4):12-8. PubMed ID: 12284919
    [Abstract] [Full Text] [Related]

  • 2. [A clinical study on the contraceptive effect of vaginal application of levonorgestrel].
    He CH.
    Shengzhi Yu Biyun; 1988 Aug; 8(3):58-60. PubMed ID: 12281927
    [Abstract] [Full Text] [Related]

  • 3. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
    Abdalla KA, Shabaan MM, Stanczyk FZ.
    Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
    [Abstract] [Full Text] [Related]

  • 4. [Application of the assays for progesterone and estradiol in saliva in family planning research].
    Zheng SH, Wang HZ, Shen WX, Sun ZD, Gao SM.
    Shengzhi Yu Biyun; 1987 Feb; 7(1):35-8. PubMed ID: 12341308
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V, Johannisson E, Landgren BM, Cekan SZ, Diczfalusy E.
    Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
    [Abstract] [Full Text] [Related]

  • 6. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U, Jung-Hoffmann C, Kuhl H.
    Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
    [Abstract] [Full Text] [Related]

  • 7. Studies on ovarian function in users of the progestagen only contraceptive pill.
    Tayob Y, Guillebaud J, Adams J, Jacobs HS.
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S91-5. PubMed ID: 12315277
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
    Kuhnz W, al-Yacoub G.
    Horm Res; 1991 Apr; 35(5):178-81. PubMed ID: 1802819
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of gestagens: some problems.
    Fotherby K.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E, Brosens I, Cornillie F, Elder M, White J, Sheppard B, Hourihan H, d'Arcangues C, Belsey EM.
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic study of levonorgestrel used as a postcoital agent.
    Shi YE, Zheng SH, Zhu YH, He CH, Yu PP, Fotherby K.
    Contraception; 1988 Apr; 37(4):359-69. PubMed ID: 3133158
    [Abstract] [Full Text] [Related]

  • 13. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Apr; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [Abstract] [Full Text] [Related]

  • 15. The vaginal contraceptive pill.
    Coutinho E.
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [Abstract] [Full Text] [Related]

  • 16. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 17. [Effects of steroid contraceptive on serum levels of sex hormone binding globulin in women].
    Zhao XJ, Shao GX, Zhang J, Sang GW.
    Shengzhi Yu Biyun; 1992 Aug; 12(4):13-7. PubMed ID: 12286664
    [Abstract] [Full Text] [Related]

  • 18. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM, Johannisson E, Aedo AR, Kumar A, Shi YE.
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [Abstract] [Full Text] [Related]

  • 19. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM, Joshi JV, Donde UM, Sankoli GM, Virkar KD, Saxena BN.
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [Abstract] [Full Text] [Related]

  • 20. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K, Kamal I, Talaat MM, Rashad S, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.